Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential. (Record no. 27989968)

MARC details
000 -LEADER
fixed length control field 00755 a2200181 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517194807.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2040-6223
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1177/2040622317735283
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Røder, Michael E
245 00 - TITLE STATEMENT
Title Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Therapeutic advances in chronic disease
Date of publication, distribution, etc. Jan 2018
300 ## - PHYSICAL DESCRIPTION
Extent 33-50 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
773 0# - HOST ITEM ENTRY
Title Therapeutic advances in chronic disease
Related parts vol. 9
-- no. 1
-- p. 33-50
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1177/2040622317735283">https://doi.org/10.1177/2040622317735283</a>
Public note Available from publisher's website

No items available.